Susan Combs Scott, MD

415 posts

Susan Combs Scott, MD

Susan Combs Scott, MD

@SusanScottMD

Thoracic Medical Oncologist at Johns Hopkins at Sibley @hopkinskimmel @sibleyonline

Baltimore, MD Katılım Şubat 2013
491 Takip Edilen946 Takipçiler
Susan Combs Scott, MD retweetledi
Coral Olazagasti, MD
Coral Olazagasti, MD@COlazagasti·
Day 2 of Winter Lung is officially underway ❄️🫁 No arctic storm in Florida @SusanScottMD & @JuliaRotow are kicking things off with The EGFR Crossfire: Monotherapy, Intensification, and Beyond What’s your 1L EGFR choice? ami/laz vs osi/chemo vs osi mono 👇 @gotoPER #WLC26
English
1
3
7
576
Susan Combs Scott, MD retweetledi
TLC Conference
TLC Conference@TLCconference·
Treatment decisions, resistance mechanisms, and the strategies you’ll take straight to clinic. Join moderator Dr. @riess_md and panelists Drs. Christina Baik, @chulkimMD, @LeXiuning, Zofia Piotrowska, @JuliaRotow, @SusanScottMD, and @jeffyoriomd for this power session on Advanced NSCLC: EGFR. We’re offering FREE REGISTRATION for a limited time to the 2-day CE-accredited #TexasLung26. Use promo code FREECME today! na2.hubs.ly/H02BzBh0 #LungCancer #EGFR
TLC Conference tweet media
English
0
4
9
1.3K
Susan Combs Scott, MD retweetledi
Ana I. Velázquez Mañana, MD, MSc, FASCO
Ana I. Velázquez Mañana, MD, MSc, FASCO@AnaVManana·
Voting for the @ASCO Election is now open! I am honored to be running as one of the candidates for the Nominating Committee seat. Visit asco.org/election to learn more about the candidates and place your vote! Thank you! 🙏
Ana I. Velázquez Mañana, MD, MSc, FASCO tweet media
English
1
20
61
14.9K
Susan Combs Scott, MD retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
Some memorable moments from #DCLung25! Mark your calendars now and save the date for #DCLung26 on Saturday October 10, 2026! You won't want to miss it!
Stephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet media
English
0
5
54
3.2K
Susan Combs Scott, MD retweetledi
Jarushka Naidoo
Jarushka Naidoo@DrJNaidoo·
#DCLung25 @SusanScottMD, an emerging leader in EGFR+ NSCLC, gives a comprehensive assessment of this space and the key questions: - FLAURA2 v MARIPOSA 1L - selection based on clinical subgroups & biologic subsets (p53+, ctDNA+) @IASLC @HopkinsThoracic #LCSM
Jarushka Naidoo tweet mediaJarushka Naidoo tweet media
English
0
4
29
1.7K
Susan Combs Scott, MD retweetledi
Jarushka Naidoo
Jarushka Naidoo@DrJNaidoo·
#DCLung25 Poignant opening to the DCLung cancer conference by @LAGurwitch on the unseen realities of patients with lung cancer: - long-term financial impact of treatment - patient navigation, should be at baseline & beyond - QOL has improved @IASLC @OncoAlert #LCSM
Jarushka Naidoo tweet mediaJarushka Naidoo tweet media
English
0
4
15
1.7K
Susan Combs Scott, MD retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
Dr. @ZPiotrowskaMD updates EGFR exon 20 NSCLC at #DCLung25. Amivantamab + chemotherapy as 1L standard of care with sunvozertinib now approved. Looking forward to novel agents like zipalertinib and furmonertinib - will these change 1L options?
Stephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet media
English
0
7
40
1.9K
Susan Combs Scott, MD retweetledi
Neal Augenstein
Neal Augenstein@AugensteinWTOP·
Here are #DCLUNG25, @SusanScottMD talks about different trials which show adding chemo, or using different drugs can extend time before cancer spreads, and overall survival. But is it worth it to add extra drugs, that can add side effects that I don’t have, w osimertinib alone?
English
1
2
3
723
Susan Combs Scott, MD retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
Overview of first-line options for #EGFR NSCLC from Dr. @SusanScottMD at #DCLung25 - it's great to have new combinations as standard of care: FLAURA2 (osimertinib + chemo) and MARIPOSA (amivantamab + lazertinib). Eye to the future - hoping for even better outcomes, biomarkers.
Stephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet media
English
2
13
49
3.2K
Susan Combs Scott, MD
Susan Combs Scott, MD@SusanScottMD·
Great to share data from PALOMA-2 looking at subq ami q4w w laz in the front line. Exciting to have a whole episode dedicated to the exciting developments in EGFR-driven NSCLC at #WCLC2025 !
IASLC@IASLC

New Lung Cancer Considered from #WCLC2025! Drs. @NarjustFlorezMD & @StephenVLiu host: 🔹 Dr. Scott on PALOMA-2 & amivantamab 🔹 Dr. Fang on EGFRxHER3 ADC 🔹 Dr. Ricciuti on FLAURA-2 OS, HARMONi & IO Listen now: bit.ly/462HfEx #IASLC #NSCLC #Oncology #CancerPodcast

English
0
0
3
1.6K
Susan Combs Scott, MD retweetledi
Joshua Reuss
Joshua Reuss@Joshua_Reuss·
🔥 start to Presidential Symposium at #WCLC25 from @dplanchard with OS results from FLAURA2 - osi + chemo vs osi. ✅️ mOS 47.5mo vs 37.6m (HR 0.77) ✅️ 4yr OS landmark 49% vs 41% ✅️ benefit observed across subgroups including mutation subtype and presence of CNS mets
Joshua Reuss tweet mediaJoshua Reuss tweet mediaJoshua Reuss tweet mediaJoshua Reuss tweet media
English
0
3
8
882
Susan Combs Scott, MD retweetledi
Alessio Cortellini
Alessio Cortellini@ACortelliniMD·
Full room despite being at the end of the meeting👌 Exciting EGFR ex20ins/uncommon data + reassuring subq amivantamab results! Thanks to speakers @ZPiotrowskaMD, @SunMinLim_, @SusanScottMD, @DrDanBreadner, @SusanScottMD for the great presentations and @IASLC for the invitation. Best part: getting to know and work with @CherylHoMD1 brilliant, friendly, smart & supportive. See you next year #WCLC2025
Alessio Cortellini tweet mediaAlessio Cortellini tweet media
Alessio Cortellini@ACortelliniMD

Excited for @IASLC #WCLC25 to kick off! On Sept 9, @CherylHoMD1 and I will co-chair: “Common and Uncommon EGFR Mutations, New Treatments in the Horizon” 📍CEST | Room 01 Highlights include: • Sunvozertinib in EGFR Ex20ins - DrMengzhaoWang • Zipalertinib post-amivantamab in Ex20ins @ZPiotrowskaMD • 1L SubQ Amivantamab ± Lazertinib (PALOMA-2) @SunMinLim_ • Zipalertinib in uncommon non-Ex20ins EGFR mut - DrHibikiUdagawa • SubQ Amivantamab + Lazertinib q4w (PALOMA-2) @SusanScottMD • Asandeutertinib vs Osimertinib (brain mets) - DrYuankai Shi • OCELOT real-world osimertinib in uncommon mut @DrDanBreadner A must attend! cattendee.abstractsonline.com/meeting/21151/…

English
3
5
32
4.3K

Keşfet

@JuliaRotow @gotoPER @riess_md @chulkimMD @LeXiuning @jeffyoriomd @ASCO @BalazsHalmosMD